Related Experiment Video
Updated: Jun 13, 2025

09:59
AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain
Published on: March 31, 2022
2.6K
Mutagenesis Sensitivity Mapping of Human Enhancers In Vivo
Michael Kosicki1, Boyang Zhang2, Anusri Pampari2,3
1Environmental Genomics & System Biology Division, Lawrence Berkeley National Laboratory, One Cyclotron Road, Berkeley, CA 94720, USA.
Biorxiv : the Preprint Server for Biology
|September 16, 2024
Summary
Human developmental enhancers have many critical DNA sequences. Most mutations disrupt enhancer function, highlighting their importance in development and disease. This study maps these essential features.
Area of Science:
- Genetics
- Developmental Biology
- Genomics
Background:
- Distant-acting enhancers are crucial for human development.
- Understanding enhancer sequence function is vital for interpreting disease-causing mutations.
Purpose of the Study:
- To determine the functional sensitivity of human developmental enhancers to mutagenesis in vivo.
- To identify critical nucleotides and sequence features within enhancers.
Main Methods:
- Systematic mutagenesis of 12-basepair blocks in seven human developmental enhancers.
- Generation of over 1700 transgenic mice to assess enhancer activity in vivo.
- Application of predictive modeling and machine learning to annotate functional nucleotides.
Main Results:
- 69% of mutated blocks impaired normal in vivo enhancer activity.
- Mutations more frequently caused loss of function (60%) than gain of function (9%).
- Machine learning models accurately predicted functional motifs, identifying 59% of functional blocks.
Conclusions:
- Human enhancers possess a high density of sequence features essential for in vivo function.
- This research provides a foundational resource for understanding enhancer function and human development.
More Related Videos
Related Concept Videos
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K

